Tibet AIM Pharm. Inc.: what insiders have been doing
This page follows insider dealings at Tibet AIM Pharm. Inc. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Nothing new has been filed by managers of Tibet AIM Pharm. Inc. in twelve months, the latest record being from 7 May 2025.
Looking back to 2021, when coverage begins, insiders filed no purchases and 4 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 100,000 shares88.0% of flowA股XSHESZSE:173000008927464500
- 10,000 shares7.9% of flowA股XSHESZSE:173000008913234850
- 5,300 shares4.1% of flowA股XSHESZSE:173000008880329800
- 20,000 shares100.0% of flowA股XSHESZSE:173000005223328350
4 of 4 declarations
About Tibet AIM Pharm. Inc.
易明医药 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
